{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "VATC|ANTIHEMORRHAGICS" in comments (approximate match)
Status:
US Approved OTC
Source:
21 CFR 349.12(c) ophthalmic:demulcents gelatin
Source URL:
First marketed in 1921
Class:
MIXTURE
Status:
US Approved Rx
(2013)
First approved in 2013
Class:
PROTEIN
Status:
US Approved Rx
(2013)
First approved in 2013
Class:
PROTEIN
Status:
US Approved Rx
(2011)
First approved in 2011
Class:
PROTEIN
Status:
US Approved Rx
(2008)
Source:
BLA125268
(2008)
Source URL:
First approved in 2008
Source:
BLA125268
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2008)
First approved in 1999
Class:
PROTEIN
Status:
US Approved Rx
(1997)
First approved in 1997
Class:
PROTEIN
Status:
US Approved Rx
(2009)
First approved in 1947
Class:
PROTEIN
Status:
US Previously Marketed
Source:
TRASYLOL by BAYER HLTHCARE
(1993)
Source URL:
First approved in 1993
Source:
TRASYLOL by BAYER HLTHCARE
Source URL:
Class:
PROTEIN
Status:
First approved in 1946
Class:
PROTEIN